2022 ICD-10-CM Diagnosis Code C77

Trang chủ » C77 » 2022 ICD-10-CM Diagnosis Code C77

Có thể bạn quan tâm

Toggle navigation Search All ICD-10 Toggle Dropdown
  • Search All ICD-10
  • ICD-10-CM Diagnosis Codes
  • ICD-10-PCS Procedure Codes
  • ICD-10-CM Diagnosis Index
  • ICD-10-CM External Causes Index
  • ICD-10-CM Table of Drugs
  • ICD-10-CM Table of Neoplasms
  • HCPCS Codes
  • ICD-9-CM Diagnosis Codes
  • ICD-9-Vol-3 Procedure Code
  • Search All Data

2025

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49
    3. ›
  3. C76-C80
    4. ›
  4. C77-
    5. ›
  5. 2025 ICD-10-CM Diagnosis Code C77
2025 ICD-10-CM Diagnosis Code C77

Secondary and unspecified malignant neoplasm of lymph nodes

    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code
  • C77 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2025 edition of ICD-10-CM C77 became effective on October 1, 2024.
  • This is the American ICD-10-CM version of C77 - other international versions of ICD-10 C77 may differ.
Type 1 ExcludesType 1 Excludes HelpA type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C77. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • malignant neoplasm of lymph nodes, specified as primary (ICD-10-CM Diagnosis Code C81

    Hodgkin lymphoma

      2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • personal history of Hodgkin lymphoma (Z85.71)
    C81-ICD-10-CM Diagnosis Code C86

    Other specified types of T/NK-cell lymphoma

      2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • anaplastic large cell lymphoma, ALK negative (C84.7-)
    • anaplastic large cell lymphoma, ALK positive (C84.6-)
    • mature T/NK-cell lymphomas (C84.-)
    • other specified types of non-Hodgkin lymphoma (C85.8-)
    C86, ICD-10-CM Diagnosis Code C88

    Malignant immunoproliferative diseases and certain other B-cell lymphomas

      2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • B-cell lymphoma, unspecified (C85.1-)
    • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)
    C88, ICD-10-CM Diagnosis Code C96
    • C96 Other and unspecified malignant neoplasms of ...
      • C96.0 Multifocal and multisystemic (disseminated) L...
      • C96.2 Malignant mast cell neoplasm
        • C96.20 …… unspecified
        • C96.21 Aggressive systemic mastocytosis
        • C96.22 Mast cell sarcoma
        • C96.29 Other malignant mast cell neoplasm
      • C96.4 Sarcoma of dendritic cells (accessory cells)
      • C96.5 Multifocal and unisystemic Langerhans-cell hi...
      • C96.6 Unifocal Langerhans-cell histiocytosis
      • C96.A Histiocytic sarcoma
      • C96.Z Other specified malignant neoplasms of lympho...
      • C96.9 Malignant neoplasm of lymphoid, hematopoietic...
    C96.-)
  • mesentary metastasis of carcinoid tumor (ICD-10-CM Diagnosis Code C7B.04

    Secondary carcinoid tumors of peritoneum

      2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code
    Applicable To
    • Mesentary metastasis of carcinoid tumor
    C7B.04)
  • secondary carcinoid tumors of distant lymph nodes (ICD-10-CM Diagnosis Code C7B.01

    Secondary carcinoid tumors of distant lymph nodes

      2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code
    C7B.01)
The following code(s) above C77 contain annotation back-referencesAnnotation Back-ReferencesIn this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C77:
  • C00-D49 2025 ICD-10-CM Range C00-D49

    NeoplasmsNote
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms

Clinical Information
  • The spread of cancer to and establishment in the lymph nodes
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change
ICD-10-CM Codes Adjacent To C77 C76.3 Malignant neoplasm of pelvis C76.4 Malignant neoplasm of upper limb C76.40 Malignant neoplasm of unspecified upper limb C76.41 Malignant neoplasm of right upper limb C76.42 Malignant neoplasm of left upper limb C76.5 Malignant neoplasm of lower limb C76.50 Malignant neoplasm of unspecified lower limb C76.51 Malignant neoplasm of right lower limb C76.52 Malignant neoplasm of left lower limb C76.8 Malignant neoplasm of other specified ill-defined sites C77 Secondary and unspecified malignant neoplasm of lymph nodes C77.0 Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck C77.1 Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes C77.2 Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes C77.3 Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes C77.4 Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes C77.5 Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes C77.8 Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions C77.9 Secondary and unspecified malignant neoplasm of lymph node, unspecified C78 Secondary malignant neoplasm of respiratory and digestive organs C78.0 Secondary malignant neoplasm of lung

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com

Từ khóa » C77